Landscapes / Companies
HUYABIO International, LLC. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
4
in active trials
Trials
4 active
10 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved in Japan | — | |||
| Also tested for | Unresectable or Metastatic Melanoma, Progressive Brain Metastasis | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Atrial Fibrillation | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Non Small Cell Lung Cancer, Colorectal Cancer and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Lung Cancer, Non Small Cell Lung Cancer and 5 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021